Outcome for children with metastatic solid tumors over the last four decades

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Perkins, Stephanie M ^a   Shinohara, Eric T ^b   DeWees, Todd ^a   Frangoul, Haydar ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DATA BASE; EWING SARCOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NEPHROBLASTOMA; NEUROBLASTOMA; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; RHABDOMYOSARCOMA; SCHOOL CHILD; SOLID TUMOR; SURVIVAL TIME; EPIDEMIOLOGICAL MONITORING; FACTUAL DATABASE; INFANT; KAPLAN MEIER METHOD; METASTASIS; NEOPLASMS; NEWBORN; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASM METASTASIS; NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84904011909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100396     Document Type: Article

References (27)

1. Kalapurakal JA, Dome JS, Perlman EJ, Malogolowkin M, Haase GM, et al. (2004) Management of Wilms' tumour: current practice and future goals. Lancet Oncol 5: 37-46.
2. Jaffe N (2009) Osteosarcoma: review of the past, impact on the future. The American experience. Cancer Treat Res 152: 239-262.
3. Balamuth NJ, Womer RB (2010) Ewing's sarcoma. Lancet Oncol 11: 184-192.
4. Park JR, Bagatell R, London WB, Maris JM, Cohn SL, et al. (2013) Children's Oncology Group's 2013 blueprint for research: neuroblastoma. Pediatr Blood Cancer 60: 985-993.
5. Malempati S, Hawkins DS (2012) Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer 59: 5-10.
6. Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, et al. (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28: 2625-2634.
7. Ladenstein R, Potschger U, Le Deley MC, Whelan J, Paulussen M, et al. (2010) Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol 28: 3284-3291.
8. Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, et al. (2004) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol 22: 4787-4794.
9. Seibel NL, Krailo M, Chen Z, Healey J, Breitfeld PP, et al. (2007) Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943. Cancer 109: 1646-1653.
10. Kager L, Zoubek A, Potschger U, Kastner U, Flege S, et al. (2003) Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 21: 2011-2018.
11. Green DM, Breslow NE, Evans I, Moksness J, D'Angio GJ (1996) Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group. Med Pediatr Oncol 26: 147-152.
12. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, et al. (2009) Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol 27: 1007-1013.
13. Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2012 Sub (1973-2010 varying) - Linked To County Attributes - Total U.S., 1969-2011 Counties, National Cancer Institute, DCCPS (released April 2013, based on the November 2012 submission): Surveillance Research Program, Surveillance Systems Branch.
14. Maurer HM, Beltangady M, Gehan EA, Crist W, Hammond D, et al. (1988) The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer 61: 209-220.
15. Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, et al. (1993) The Intergroup Rhabdomyosarcoma Study-II. Cancer 71: 1904-1922.
16. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, et al. (1995) The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13: 610-630.
17. Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, et al. (2003) Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21: 78-84.
18. Jaffe N, Paed D, Traggis D, Salian S, Cassady JR (1976) Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy. Cancer 38: 1925-1930.
19. Nesbit ME Jr., Gehan EA, Burgert EO Jr., Vietti TJ, Cangir A, et al. (1990) Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol 8: 1664-1674.
20. Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, et al. (2003) Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348: 694-701.
21. Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, et al. (2012) Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol 30: 4148-4154.
22. Meyers PA, Heller G, Healey JH, Huvos A, Applewhite A, et al. (1993) Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 11: 449-453.
23. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, et al. (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341: 1165-1173.
24. Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, et al. (2010) Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 363: 1324-1334.
25. Green DM (2013) The evolution of treatment for Wilms tumor. J Pediatr Surg 48: 14-19.
26. Breslow NE, Churchill G, Nesmith B, Thomas PR, Beckwith JB, et al. (1986) Clinicopathologic features and prognosis for Wilms' tumor patients with metastases at diagnosis. Cancer 58: 2501-2511.
27. Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, et al. (2006) Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol 24: 2352-2358.